Obicetrapib + ezetimibe

1. Obicetrapib + ezetimibe decreases LDL-C in humans (-49.15% (95% CI: -59.42 to -38.89)).

   Reviewdyslipidaemia10 mg plus 10 mg

   Efficacy and Safety of Oral Non-Statin Lipid-Lowering Therapies in Dyslipidaemia: A Systematic Review and Network Meta-Analysis · Endocrinology, diabetes & metabolism · 1 Oct 2026

LDL-C →